Literature DB >> 20618793

Net clinical benefit: the art and science of jointly estimating benefits and risks of medical treatment.

Adrian Towse1.   

Abstract

Mesh:

Year:  2010        PMID: 20618793     DOI: 10.1111/j.1524-4733.2010.00753.x

Source DB:  PubMed          Journal:  Value Health        ISSN: 1098-3015            Impact factor:   5.725


× No keyword cloud information.
  3 in total

1.  Should benefit-risk assessment have its own drug "label"?

Authors:  R Scott Braithwaite
Journal:  Drug Healthc Patient Saf       Date:  2011-08-03

2.  Adjuvant trastuzumab regimen for HER2-positive early-stage breast cancer: a systematic review and meta-analysis.

Authors:  Anne Julienne Genuino; Usa Chaikledkaew; Due Ong The; Thanyanan Reungwetwattana; Ammarin Thakkinstian
Journal:  Expert Rev Clin Pharmacol       Date:  2019-07-09       Impact factor: 5.045

3.  Impact of Polypharmacy and P-Glycoprotein- and CYP3A4-Modulating Drugs on Safety and Efficacy of Oral Anticoagulation Therapy in Patients with Atrial Fibrillation.

Authors:  Ralf E Harskamp; Martina Teichert; Wim A M Lucassen; Henk C P M van Weert; Renato D Lopes
Journal:  Cardiovasc Drugs Ther       Date:  2019-10       Impact factor: 3.727

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.